Patents Represented by Attorney, Agent or Law Firm Millen White Zelano & Branigan
  • Patent number: 8143172
    Abstract: The present invention relates to a novel printable etching medium having non-Newtonian flow behavior for the etching of surfaces in the production of solar cells, and to the use thereof. The present invention furthermore also relates to etching and doping media which are suitable both for the etching of inorganic layers and also for the doping of underlying layers. In particular, they are corresponding particle-containing compositions by means of which extremely fine structures can be etched very selectively without damaging or attacking adjacent areas.
    Type: Grant
    Filed: June 21, 2006
    Date of Patent: March 27, 2012
    Assignee: Merck Patent GmbH
    Inventors: Werner Stockum, Armin Kuebelbeck, Jun Nakanowatari
  • Patent number: 8143381
    Abstract: The present invention relates to the use of ionic liquids or of mixtures comprising at least one ionic liquid and at least one further solvent for the extraction of membrane proteins from biological samples, to methods for the extraction of membrane proteins, to a kit for the extraction of these proteins and to the use thereof.
    Type: Grant
    Filed: October 18, 2007
    Date of Patent: March 27, 2012
    Assignee: Merck Patent GmbH
    Inventors: Joerg Von Hagen, Uwe Michelsen, Maria Wehsling
  • Patent number: 8138232
    Abstract: The invention relates to a method for recycling plastic materials which contain at least two polymers, copolymers or blends thereof based on polystyrene. The plastic material is thereby mixed with a solvent for the polymers, copolymers or blends. Subsequently a precipitation is effected by addition of a corresponding precipitant so that then the gelatinous precipitation product can be separated from the further components of the plastic material. The method is used for recycling of any plastic materials, in particular of plastic materials from electronic scrap processing and from shredder light fractions.
    Type: Grant
    Filed: June 8, 2006
    Date of Patent: March 20, 2012
    Assignee: Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung E.V.
    Inventors: Andreas Maeurer, Martin Schlummer, Otto Beck
  • Patent number: 8137532
    Abstract: The invention concerns a process for producing middle distillates from a paraffinic feed produced by Fischer-Tropsch synthesis, using a hydrocracking/hydroisomerization catalyst which comprises 0.2% to 2.5% by weight of an oxide of a doping element selected from boron, phosphorus, silicon, at least one hydrodehydrogenating element selected from the group formed by noble elements from group VIII of the periodic table, a non-zeolitic support based on silica-alumina containing more than 5% by weight and 95% by weight or less of silica (SiO2), specifically defined pore characteristics, a BET specific surface area in the range 100 to 550 m2/g, and with an X ray diffraction diagram which contains at least the characteristic principal peaks of at least one of the transition aluminas included in the group composed of alpha, rho, khi, eta, gamma, kappa, theta and delta aluminas.
    Type: Grant
    Filed: December 14, 2006
    Date of Patent: March 20, 2012
    Assignee: IFP Energies Nouvelles
    Inventors: Patrick Euzen, Christophe Gueret
  • Patent number: 8133887
    Abstract: The invention relates to compounds of the formula (I), in which R1, R2, R3, R4, Y and A have the meanings indicated, and to processes for the preparation thereof and to the use thereof for the preparation of medicaments.
    Type: Grant
    Filed: November 29, 2006
    Date of Patent: March 13, 2012
    Assignee: Merck Patent GmbH
    Inventors: Andreas Taugerbeck, Detlef Pauluth, Beate Kretschmer, Hanns Wurziger, Axel Jansen, David Maillard
  • Patent number: 8132777
    Abstract: A blowout preventer for use in the oil and gas industry having a single modified, dual-acting hydraulic operator per door, comprising a reconfigured adapter. The reconfigured adapter comprises a body having a longitudinal bore, a plurality of hydraulic fluid passageways therethrough, and is slidably received by the blowout preventer.
    Type: Grant
    Filed: January 23, 2008
    Date of Patent: March 13, 2012
    Assignee: Alberta Petroleum Industries Ltd.
    Inventors: Scott Delbridge, Dean Foote
  • Patent number: 8134003
    Abstract: The present invention relates generally to the field of ligands for nicotinic acetylcholine receptors (nAChR), activation of nAChRs, and the treatment of disease conditions associated with defective or malfunctioning nicotinic acetylcholine receptors, especially of the brain. Further, this invention relates to novel compounds (indazoles and benzothiazoles), which act as ligands for the ?7 nAChR subtype, methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.
    Type: Grant
    Filed: May 9, 2011
    Date of Patent: March 13, 2012
    Assignee: Memory Pharmaceuticals Corporation
    Inventors: Wenge Xie, Brian Herbert, Truc Nguyen, Carla Gauss, Ashok Tehim
  • Patent number: 8133913
    Abstract: Synthesis of novel substituted indeno[1,2-b]indole derivatives of the type of 5,6,7,8-tetrahydroindeno[1,2-b]indole-9,10-diones and 5H-indeno[1,2-b]indole-6,9,10-triones, which show pronounced inhibition of the human protein kinase CK2, and the use thereof as active ingredients in medicaments and/or drug products in particular for the treatment of neoplastic diseases.
    Type: Grant
    Filed: October 4, 2007
    Date of Patent: March 13, 2012
    Assignee: Heinrich-Heine Universitat Dusseldof
    Inventors: Hans-Jorg Hemmerling, Claudia Gotz, Joachim Jose
  • Patent number: 8133445
    Abstract: This invention relates to a chamber in which a chemical reaction is carried out in the presence of catalyst and reagents, comprising at least one catalytic tube (10) into which is placed an internal tube (12) for evacuating the gas that is produced, means for introducing reagents (15) and means for introducing the catalyst (16) that are located in the upper portion of the chamber (1), means for heating the catalytic tube (10) that are arranged in the lower portion of the chamber (1), and in which the catalytic tube (10) comprises, in its upper portion above the catalyst (13), means that promote heat exchange between the reagents and the gas that is produced. The invention also relates to the process that uses this chamber.
    Type: Grant
    Filed: October 5, 2009
    Date of Patent: March 13, 2012
    Assignee: IFP Energies Nouvelles
    Inventors: Christophe Boyer, Fabrice Giroudiere
  • Patent number: 8129373
    Abstract: Novel compounds of the formula (I), in which D, E, G, W, X, Y, T, R1 and R2 are as defined in Patent Claim 1, are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumors.
    Type: Grant
    Filed: June 17, 2010
    Date of Patent: March 6, 2012
    Assignee: Merck Patent GmbH
    Inventors: Christos Tsaklakidis, Dieter Dorsch, Werner Mederski, Bertram Cezanne, Johannes Gleitz
  • Patent number: 8129714
    Abstract: A semiconductor device including a semiconductor 1, a first electrode 2, an insulating layer 3 interposed between the semiconductor 1 and the first electrode 2, the second electrode 4 which is in contact with the semiconductor 1 and is detached from the first electrode 2, and the third electrode 5 which is in contact with the semiconductor 1 and is detached from the first electrode 2 and the second electrode 4, wherein the semiconductor 1 is provided with the organic semiconductor layer 10 and the oxide semiconductor layer 11.
    Type: Grant
    Filed: June 5, 2007
    Date of Patent: March 6, 2012
    Assignee: Idemitsu Kosan Co., Ltd.
    Inventors: Koki Yano, Hajime Nakanotani, Chihaya Adachi
  • Patent number: 8129331
    Abstract: Disclosed are peptides that bind to Ang-2. Also disclosed are peptibodies comprising the peptides, methods of making such peptides and peptibodies, and methods of treatment using such peptides and peptibodies.
    Type: Grant
    Filed: December 7, 2007
    Date of Patent: March 6, 2012
    Assignee: Amgen Inc.
    Inventors: Jonathan Daniel Oliner, Hosung Min
  • Patent number: 8128935
    Abstract: The present invention relates to the provision of the genetic sequence of the major grass pollen allergen Phl p 4. The invention also covers fragments, new combinations of partial sequences and point mutants having a hypoallergenic action. The recombinant DNA molecules and the derived polypeptides, fragments, new combinations of partial sequences and variants can be utilised for the therapy of pollen-allergic diseases. The proteins prepared by recombinant methods can be employed for the in vitro and in vivo diagnosis of pollen allergies.
    Type: Grant
    Filed: June 11, 2003
    Date of Patent: March 6, 2012
    Assignee: Merck Patent GmbH
    Inventors: Helmut Fiebig, Andreas Nandy, Roland Suck, Oliver Cromwell, Arnd Petersen, Wolf-Meinhard Becker
  • Patent number: 8129002
    Abstract: The present invention is related to compounds for use in liquid crystal media, liquid crystal media comprising said compounds, the use of said media in electro-optical devices, said electro-optical devices, and the use of said compounds in mesogenic media for use in electro-optical devices that may be operated in an optically isotropic state.
    Type: Grant
    Filed: July 28, 2004
    Date of Patent: March 6, 2012
    Assignee: Merck Patent GmbH
    Inventors: Peer Kirsch, Elvira Montenegro, Louise Diane Farrand, Detlef Pauluth, Michael Heckmeier
  • Patent number: 8124782
    Abstract: The present invention relates to a process for preparing 4-{4-[({[4-chloro-3-(trifluoro-methyl)phenyl]amino}carbonyl)amino]phenoxy}-N-methylpyridine-2-carboxamide and its tosylate salt.
    Type: Grant
    Filed: September 20, 2005
    Date of Patent: February 28, 2012
    Assignee: Bayer Pharma Aktiengesellschaft
    Inventors: Michael Lögers, Reinhold Gehring, Oliver Kuhn, Mike Matthäus, Klaus Mohrs, Matthias Müller-Gliemann, Jürgen Stiehl, Mathias Berwe, Jana Lenz, Werner Heilmann
  • Patent number: 8124613
    Abstract: Compounds according to formula (I): wherein R1, R2, R3, n and X are defined as defined herein, and the pharmaceutically acceptable salts, hydrates and solvates thereof, are useful for the modulation of CCR5 chemokine receptor activity. Additionally, compounds according to Formula III: wherein Z, R?1, and R?2 are defined as defined herein, and the pharmaceutically acceptable salts, hydrates and solvates thereof, are useful as intermediates for production of compounds that modulate CCR5 chemokine receptor activity.
    Type: Grant
    Filed: June 14, 2007
    Date of Patent: February 28, 2012
    Assignee: Virochem Pharma Inc.
    Inventors: Christophe Moinet, Charles Blais, Monica Bubenik, Laval Chan Chun Kong, Marc Courchesne, Oswy Z. Pereira, Réal Denis, Louis Vaillancourt, Constantin G. Yannopoulos
  • Patent number: 8124817
    Abstract: In a process for the preparation of ring compounds via a combinatorial synthesis, the reaction procedure is based on a Suzuki coupling, subsequent halo-demetallation and finally a further Suzuki coupling. The Suzuki couplings are each carried out with a boronic acid or a boronic acid ester. The reaction procedure uses provides novel ring compounds and uses novel synthesis units used for this purpose. The novel ring compounds are suitable for use as constituents in liquid-crystalline mixtures.
    Type: Grant
    Filed: October 19, 2010
    Date of Patent: February 28, 2012
    Assignee: Merck Patent GmbH
    Inventors: Detlef Pauluth, Peer Kirsch, Peter Baeuerle, Oliver Deeg
  • Patent number: 8124038
    Abstract: The invention relates to a crystallized solid, denoted by the name IM-16, which has an X-ray diffraction pattern as provided hereinafter. Said solid has a chemical composition expressed in accordance with the empirical formula mXO2:nGeO2:pZ2O3:qR:sF:wH2O, where R represents one or more organic species, X represents one or more tetravalent elements different from germanium, Z represents at least one trivalent element and F is fluorine.
    Type: Grant
    Filed: June 24, 2008
    Date of Patent: February 28, 2012
    Assignee: IFP Energies Nouvelles
    Inventors: Yannick Lorgouilloux, Jean-Louis Paillaud, Philippe Caullet, Joel Patarin, Nicolas Bats
  • Patent number: 8123950
    Abstract: A process for separating a feed F by simulated moving bed adsorption in a SMB device is described, the device comprising external bypass lines Li/i+1 which directly connect two successive plates Pi, Pi+1, the index i being either even or (exclusive of the foregoing) odd, along the whole length of the column, in order to flush said plates, in which each of the bypass lines Li/i+1 comprises automated means for regulating the flow rate in the bypass lines, the degree of opening of said regulating means being defined by the following three rules: a) establishing a flow rate corresponding to an oversynchronicity in the range 15% to 30% in all of the open bypass lines of zone 1; b) establishing a flow rate corresponding to the synchronicity to within plus or minus 8% in all of the open bypass lines of zones 2 and 3; c) establishing a flow rate corresponding to an oversynchronicity in the range 20% to 40% in all of the open bypass lines of zone 4.
    Type: Grant
    Filed: April 9, 2010
    Date of Patent: February 28, 2012
    Assignee: IFP Energies Nouvelles
    Inventors: Xavier Decoodt, Gerard Hotier, Philibert LeFlaive, Damien Leinekugel Le Cocq
  • Patent number: 8123952
    Abstract: A process for separating a feed F by simulated moving bed adsorption in a SMB device comprises at least one zone 1 for desorption of the compounds produced in the extract, a zone 2 for desorption of the compounds produced in the raffinate, a zone 3 for adsorption of the compounds produced in the extract, a zone 4 located between the raffinate withdrawal and the desorbant supply, the device comprising external by-pass lines Li/i+1 directly connecting two successive plates Pi and Pi+1; in which the degree of opening of means for restricting the flushing flow rate of the by-pass lines Li/i+1 are sequentially modified such that: 1) in an operational zone where there is at least one closed by-pass line, a super-synchronicity of the flushing flow rate is established in all of the by-pass lines which are not closed belonging to the zone under consideration, said super-synchronicity being defined by the following formula: S=a+b(nf/nt) in which the constant a is a constant in the range ?5 to 5 and b is a constant
    Type: Grant
    Filed: July 29, 2009
    Date of Patent: February 28, 2012
    Assignee: IFP Energies Nouvelles
    Inventors: Xavier Decoodt, Gerard Hotier, Philibert Leflaive, Damien Leinekugel Le Cocq